Sign in

TAKEDA PHARMACEUTICAL CO LTD

Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08 Mar-07
Total revenue 4,777.45 4,581.55 4,263.76 4,027.48 3,569.01 3,197.81 3,291.19 2,097.22 1,770.53 1,732.05 1,807.38 1,777.82 1,691.69 1,557.27 1,508.93 1,419.39 1,465.97 1,538.34 1,374.80 1,305.17
Cost of revenue 2,338.12 1,580.22 1,431.51 1,244.07 1,106.85 994.31 1,089.76 659.69 495.92 558.76 535.41 520.99 490.26 447.63 433.19 317.58 285.06 289.54 278.63 279.66
Gross profit 2,439.33 3,001.33 2,832.26 2,783.41 2,462.16 2,203.50 2,201.42 1,437.53 1,274.61 1,173.30 1,271.97 1,256.83 1,201.42 1,109.64 1,075.74 1,101.80 1,180.90 1,248.79 1,096.17 1,025.51
Total operating expenses + 1,866.29 2,658.75 2,618.18 2,292.90 2,001.32 1,694.24 2,101.02 1,277.17 1,032.82 1,017.43 1,141.15 1,386.09 1,062.15 987.13 810.71 734.72 760.69 942.33 673.05 567.01
Operating income 573.04 342.59 214.08 490.51 460.84 509.27 100.41 204.97 241.79 155.87 130.83 -129.25 139.27 122.51 265.03 367.08 420.21 306.47 423.12 458.50
Non-operating income (net) -297.16 -167.50 -161.28 -115.42 -158.27 -143.03 -161.16 -110.07 -24.58 -12.52 -10.29 -16.18 19.58 7.20 -12.55 4.49 -4.38 92.08 153.72 166.88
Income before tax 275.88 175.08 52.79 375.09 302.57 366.24 -60.75 94.90 217.21 143.35 120.54 -145.44 158.85 129.71 252.48 371.57 415.83 398.55 576.84 625.38
Income tax expense 72.27 66.94 -91.41 58.05 72.41 -9.94 -105.04 -14.12 30.50 27.83 37.06 -2.40 49.29 -3.88 125.21 121.33 115.67 161.35 218.77 285.84
Net income 203.33 107.93 144.07 317.02 230.06 376.01 44.24 109.13 186.89 114.94 80.17 -145.78 106.66 131.24 124.16 247.87 297.74 234.39 355.45 335.81
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08
Total revenue 1,114.65 1,213.21 1,112.80 1,106.69 1,053.40 1,144.12 1,176.04 1,207.99 1,050.87 1,111.19 1,043.09 1,058.62 956.16 1,096.55 1,002.31 972.47 873.29 901.29 844.82 949.60 770.27 836.75 788.94 801.85 771.70 859.32 811.05 849.12 717.21 499.40 430.78 449.83 400.96 488.15 433.18 448.24 416.21 465.05 416.80 434.01 414.12 489.21 457.75 446.30 437.84 488.63 440.20 411.15 404.81 458.82 417.74 410.30 368.16 402.17 388.64 398.29 381.32 425.11 345.28 357.22 338.26 367.11 359.33 354.70 338.02 372.49 376.48 378.98 335.58 395.62 410.26
Cost of revenue 570.84 552.87 380.06 384.68 382.10 416.87 394.31 386.95 387.33 379.48 343.58 321.11 309.77 335.97 305.45 292.88 308.38 281.40 275.80 241.26 253.45 253.14 249.64 238.08 248.18 279.58 271.71 300.59 289.84 138.51 110.75 120.59 110.89 142.29 121.87 120.87 134.41 147.49 141.46 135.40 132.97 145.03 136.29 121.12 134.58 139.42 128.95 118.04 130.94 131.54 120.14 115.09 111.07 120.50 112.75 103.31 128.18 145.45 80.67 78.90 82.89 84.11 77.48 73.10 70.44 74.25 69.05 71.34 68.27 70.56 72.08
Gross profit 543.81 660.35 732.74 722.01 671.30 727.25 781.73 821.04 663.54 731.71 699.51 737.50 646.38 760.58 696.86 679.58 564.91 619.89 569.02 708.34 516.83 583.61 539.29 563.77 523.52 579.74 539.34 548.53 427.38 360.89 320.03 329.24 290.07 345.86 311.30 327.37 281.80 317.56 275.33 298.61 281.16 344.18 321.46 325.17 303.26 349.21 311.26 293.11 273.87 327.28 297.60 295.21 257.09 281.68 275.90 294.98 253.15 279.65 264.62 278.32 255.37 282.99 281.85 281.60 267.58 298.25 307.43 307.64 267.30 325.06 338.18
Total operating expenses + 496.27 466.28 663.74 537.44 746.20 660.31 597.48 654.71 673.61 626.79 748.85 568.93 557.82 613.59 592.43 529.07 566.53 503.41 471.60 459.79 366.29 440.47 490.99 396.49 585.66 526.23 498.89 538.66 551.43 248.42 246.94 230.37 370.57 257.93 271.93 132.40 343.36 262.20 266.19 145.68 317.81 287.15 260.57 275.62 631.56 266.86 258.25 229.42 303.95 260.50 244.90 247.51 285.25 547.20 75.80 78.88 620.97 70.74 61.29 57.72 544.72 65.81 62.08 62.11 551.41 73.70 70.71 64.87 564.73 56.53 86.24
Operating income 47.54 194.06 69.00 184.57 -74.90 66.94 184.25 166.33 -10.07 104.91 -49.34 168.57 88.56 146.99 104.44 150.52 -1.62 116.48 97.43 248.55 150.54 143.14 48.30 167.29 -62.14 53.51 40.44 9.87 -79.45 112.46 73.09 98.87 -80.50 87.94 39.37 194.98 -61.56 55.35 9.14 152.93 -36.65 57.03 60.89 49.56 -328.31 82.36 53.01 63.69 -30.08 66.79 52.70 47.71 -28.17 -265.53 200.10 216.10 -367.82 208.92 203.33 220.60 -289.35 217.19 219.76 219.48 -283.83 224.55 236.72 242.77 -297.42 268.53 251.94
Non-operating income (net) -100.98 -57.78 -40.82 -33.94 -32.40 -40.54 -64.88 -29.73 -37.45 -43.65 -46.64 -33.12 -40.65 -39.84 -39.02 5.46 -52.43 -44.29 -35.98 -25.57 -19.66 -33.35 -53.03 -36.99 -54.63 -28.67 -42.82 -35.05 -34.03 -64.87 -6.17 -5.01 9.81 -33.04 -4.63 3.27 -3.91 -1.55 -3.80 -3.26 2.58 -4.46 -7.57 -0.84 -4.70 -7.93 0.14 -3.70 8.67 12.00 11.69 2.48 -8.09 301.17 -145.51 -140.37 337.59 -135.75 -113.02 -101.37 324.44 -106.18 -98.13 -115.65 330.40 -110.19 -119.41 -105.18 368.41 -117.23 -143.47
Income before tax -53.44 136.28 28.17 150.63 -107.30 26.41 119.37 136.60 -47.52 61.26 -95.98 135.45 47.92 107.15 65.42 155.97 -54.05 72.19 61.45 222.98 130.88 109.80 -4.73 130.29 -116.76 24.84 -2.37 -25.19 -113.48 47.60 66.92 93.86 -70.69 54.90 34.75 198.24 -65.47 53.80 5.34 149.68 -34.07 52.57 53.32 48.72 -333.00 74.43 53.15 59.99 -21.42 78.79 64.39 50.19 -36.26 35.64 54.59 75.73 -30.24 73.17 90.32 119.24 35.09 111.00 121.64 103.83 46.57 114.36 117.31 137.59 70.98 151.30 108.47
Income tax expense -28.74 30.67 39.90 26.35 -4.20 2.57 27.27 41.30 -44.53 -44.50 -48.01 45.63 16.78 -12.00 2.82 50.45 -42.67 14.37 15.45 85.25 -66.27 17.36 -8.80 47.77 -118.32 56.95 -56.29 -4.55 -58.14 9.74 18.51 15.78 -16.71 -13.12 7.07 53.25 -12.95 11.37 -19.92 49.33 -1.18 -7.81 22.76 23.29 -107.63 55.24 24.30 25.68 -16.52 22.52 20.45 20.48 -29.42 16.46 21.70 -12.62 5.68 47.43 29.49 42.62 2.62 38.90 40.83 38.99 7.54 44.11 39.68 24.35 4.89 53.73 38.50
Net income -24.77 105.51 -11.80 124.24 -103.20 23.79 92.05 95.25 -3.02 105.72 -48.03 89.40 31.13 119.13 61.74 105.01 -11.36 57.77 45.96 137.68 197.10 92.36 4.04 82.51 1.72 -32.22 53.84 -20.66 -55.31 37.77 48.43 78.24 -54.02 68.09 28.03 144.79 -50.73 41.37 24.77 99.53 -33.48 59.26 29.80 24.58 -225.52 18.31 28.04 33.40 -4.34 54.53 42.80 29.08 -7.67 19.12 32.23 87.56 -36.45 24.95 60.08 75.58 32.38 71.28 80.10 64.11 38.60 69.52 77.04 112.59 65.81 96.79 69.29
about 2 months ago
Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08 Mar-07
Total cash and short-term investments + 597.63 405.59 472.89 553.70 875.00 1,002.82 653.44 725.37 375.17 376.14 560.03 713.42 851.03 305.85 460.52 219.41 883.22 758.78 3,058.71 1,799.94
Accounts receivable, net 880.15 725.25 697.61 681.69 724.38 812.71 784.92 749.12 428.79 444.78 430.57 466.83 442.66 387.02 361.87 283.59 279.70 301.45 388.25 400.66
Inventories 1,402.68 1,217.35 1,209.87 986.46 853.17 753.88 759.60 986.74 212.94 226.29 254.01 262.35 254.33 229.53 195.01 137.13 137.70 131.66 116.13 105.31
Other current assets 223.45 173.00 178.21 176.10 141.10 143.48 271.48 598.88 61.90 213.45 129.18 77.47 44.51 53.31 43.28 574.91 551.96 585.15 442.67 452.47
Total current assets 3,103.91 2,521.19 2,558.58 2,397.96 2,593.64 2,712.89 2,469.43 3,050.66 1,078.81 1,260.66 1,373.79 1,520.07 1,592.54 1,455.08 1,279.00 1,586.25 1,572.87 1,475.58 2,243.79 2,357.71
Total non-current assets + 12,416.23 11,727.15 12,550.21 11,559.79 10,584.38 10,199.40 10,351.66 10,799.74 3,027.66 3,086.38 2,450.30 2,776.12 2,976.61 2,821.15 2,544.57 1,200.15 1,250.40 1,284.60 605.49 714.79
Total assets 15,520.14 14,248.34 15,108.79 13,957.75 13,178.02 12,912.29 12,821.09 13,872.32 4,106.46 4,355.78 3,824.09 4,296.19 4,569.14 3,955.60 3,577.03 2,786.40 2,823.27 2,760.19 2,849.28 3,072.50
Total current liabilities + 2,440.07 2,506.52 2,313.10 2,481.94 2,145.73 1,773.18 2,175.90 2,510.93 737.51 1,366.09 857.21 1,016.82 802.75 613.63 751.73 436.60 428.48 472.11 428.71 442.41
Total non-current liabilities + 5,271.55 4,805.84 5,521.68 5,121.14 5,348.77 5,961.94 5,917.71 6,197.80 1,351.55 1,040.73 955.67 1,073.19 1,225.76 1,118.61 753.43 213.15 230.05 234.24 98.04 168.98
Total liabilities 7,711.62 7,312.37 7,834.79 7,603.08 7,494.50 7,735.12 8,093.61 8,708.73 2,089.05 2,406.82 1,812.88 2,090.02 2,028.51 1,732.24 1,505.16 649.75 658.53 706.35 526.75 611.39
Total stockholders' equity + 7,807.31 6,935.08 7,273.26 6,354.12 5,683.02 5,173.04 4,723.48 5,159.58 1,997.42 1,894.26 1,948.69 2,137.05 2,470.74 2,159.94 2,012.35 2,091.92 2,121.34 2,011.45 2,280.78 2,420.25
Common shares outstanding 3,206 3,211 3,161 3,140 3,154 3,147 3,132 1,934 1,573 1,572 1,576 1,573 1,581 1,579 1,579 1,579 1,579 1,618 1,697 1,740
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08
Total cash and short-term investments + 597.63 762.39 739.68 419.18 405.59 526.75 906.22 857.66 472.89 317.40 333.81 368.61 553.70 726.61 830.07 664.53 875.00 751.90 633.62 684.85 1,002.82 654.30 646.18 600.93 653.44 588.42 557.43 615.09 725.37 1,864.20 337.36 250.63 375.17 466.48 460.67 490.28 376.14 738.45 739.18 732.77 560.03 660.51 667.59 637.92 713.42 856.50 841.36 762.74 851.03 732.65 719.14 384.88 305.85 422.09 412.02 381.33 460.52 384.44 405.94 820.34 219.41 762.38 805.57 771.18 883.22 807.40 808.31 0.00 758.78 606.60 0.00
Accounts receivable, net 880.15 758.44 702.24 679.53 725.25 735.06 721.06 772.37 697.61 743.08 788.07 825.48 681.69 779.87 800.54 794.09 724.38 756.12 887.30 858.96 812.71 828.94 769.81 815.27 784.92 852.13 805.74 788.63 749.12 515.79 468.92 459.72 428.79 518.69 470.86 471.16 444.78 496.86 446.20 440.42 430.57 493.73 478.37 479.83 466.83 500.22 461.78 442.09 442.66 423.63 382.12 363.65 387.02 377.10 546.59 547.44 361.87 600.29 577.05 519.68 523.90 534.67 521.39 517.74 516.89 520.17 524.89 520.55 508.48
Inventories 1,402.68 1,408.15 1,299.49 1,240.68 1,217.35 1,246.43 1,206.43 1,276.74 1,209.87 1,169.64 1,155.87 1,083.37 986.46 927.29 953.45 927.51 853.17 811.32 783.48 779.15 753.88 739.35 743.48 759.38 759.60 801.34 840.84 902.52 986.74 223.40 233.30 221.42 212.94 225.10 234.30 234.68 226.29 222.91 237.92 242.20 254.01 268.74 275.00 277.63 262.35 282.66 277.42 267.58 254.33 251.90 238.53 237.52 229.53 224.49 208.44 203.52 195.01 209.52 241.31 139.86 137.13 135.99 135.43 135.65 137.70 138.76 135.92 131.66 127.17
Other current assets 223.45 190.03 179.22 173.74 173.00 246.05 220.31 200.77 178.21 198.71 184.33 194.55 176.10 162.18 161.56 163.38 141.10 158.56 151.96 153.50 143.48 394.01 425.67 299.19 271.48 278.43 170.43 625.92 598.88 66.68 68.36 111.78 61.90 55.71 56.17 74.70 213.45 198.04 61.00 58.14 129.18 126.73 59.27 76.10 77.47 64.41 53.09 58.95 44.51 799.75 755.28 759.88 53.31 684.67 621.31 612.34 43.28 646.96 627.25 583.25 574.91 583.89 560.06 559.35 551.96 550.72 561.80 585.15 573.82
Total current assets 3,103.91 3,118.57 2,920.62 2,513.12 2,521.19 2,754.29 3,054.01 3,107.53 2,558.58 2,428.83 2,462.07 2,472.02 2,397.96 2,595.95 2,745.62 2,549.52 2,593.64 2,477.89 2,456.35 2,476.46 2,712.89 2,616.60 2,585.14 2,474.76 2,469.43 2,520.33 2,374.44 2,932.16 3,050.66 2,670.07 1,107.94 1,043.55 1,078.81 1,265.98 1,222.00 1,270.82 1,260.66 1,656.26 1,484.30 1,473.53 1,373.79 1,549.71 1,480.22 1,471.48 1,520.07 1,703.79 1,633.65 1,531.36 1,592.54 1,784.30 1,712.95 1,382.29 1,455.08 1,331.25 1,241.77 1,197.19 1,279.00 1,240.92 1,274.50 1,543.46 1,586.25 1,482.26 1,501.06 1,466.18 1,572.87 1,496.89 1,506.03 1,475.58 1,307.59
Total non-current assets + 12,416.23 12,300.73 11,549.68 11,491.42 11,727.15 12,352.56 11,518.99 13,120.15 12,550.21 11,794.12 12,409.82 12,320.72 11,559.79 10,908.76 11,843.23 11,515.91 10,584.38 10,220.63 10,103.92 10,180.78 10,199.40 9,669.54 9,829.61 10,139.09 10,351.66 10,511.17 10,505.70 10,618.27 10,799.74 3,097.15 3,166.90 3,116.03 3,027.66 3,144.58 3,153.96 3,075.11 3,086.38 2,485.77 2,317.52 2,343.48 2,450.30 2,640.17 2,733.61 2,849.37 2,776.12 2,949.58 2,938.16 2,905.97 2,976.61 2,641.49 2,540.27 2,551.42 2,821.15 2,452.48 2,240.40 2,270.76 2,544.57 2,180.46 2,224.78 1,170.11 1,200.15 1,197.81 1,207.61 1,218.17 1,250.40 1,256.43 1,233.90 1,284.60 1,247.06
Total assets 15,520.14 15,419.29 14,470.30 14,004.54 14,248.34 15,106.84 14,573.00 16,227.68 15,108.79 14,222.95 14,871.89 14,792.74 13,957.75 13,504.71 14,588.85 14,065.43 13,178.02 12,698.52 12,560.27 12,657.23 12,912.29 12,286.14 12,414.75 12,613.85 12,821.09 13,031.49 12,880.14 13,550.42 13,872.32 5,767.22 4,274.84 4,159.58 4,106.46 4,410.56 4,375.96 4,345.92 4,355.78 4,142.03 3,801.82 3,817.01 3,824.09 4,189.88 4,213.83 4,320.85 4,296.19 4,653.37 4,571.81 4,437.33 4,569.14 4,425.79 4,253.22 3,933.71 3,955.60 3,783.73 3,482.16 3,467.95 3,577.03 3,421.38 3,499.28 2,713.57 2,786.40 2,680.07 2,708.67 2,684.35 2,823.27 2,753.32 2,739.93 2,760.19 2,760.19 2,554.65 2,554.65
Total current liabilities + 2,440.07 2,611.96 2,139.66 2,169.59 2,506.52 2,097.96 2,387.24 2,465.20 2,313.10 2,282.17 2,367.62 2,501.74 2,481.94 2,236.81 2,391.72 2,166.94 2,145.73 1,809.25 1,918.75 1,706.78 1,773.18 1,804.96 1,709.66 2,031.54 2,175.90 2,127.37 1,634.63 2,006.62 2,510.93 871.71 844.19 733.44 737.51 878.17 838.77 939.62 1,366.09 957.95 808.84 822.76 857.21 1,011.25 985.98 1,010.95 1,016.82 837.92 779.16 740.64 802.75 581.08 546.99 543.62 613.63 572.79 488.28 726.44 751.73 1,027.03 1,017.20 389.44 436.60 375.07 375.45 368.00 428.48 426.45 429.92 472.11 409.77
Total non-current liabilities + 5,271.55 5,158.02 5,198.96 4,968.77 4,805.84 5,589.69 5,264.17 5,963.25 5,521.68 5,198.17 5,433.25 5,369.33 5,121.14 5,091.40 5,483.64 5,581.10 5,348.77 5,557.44 5,317.16 5,711.81 5,961.94 5,841.75 6,038.59 5,891.54 5,917.71 6,027.91 6,375.82 6,669.35 6,197.80 2,852.94 1,258.49 1,359.56 1,351.55 1,398.31 1,431.49 1,369.52 1,040.73 1,139.68 1,113.94 1,124.97 955.67 1,016.26 1,045.54 1,078.28 1,073.19 1,242.59 1,261.71 1,242.69 1,225.76 1,391.46 1,359.06 1,113.58 1,118.61 1,088.52 1,022.68 791.32 753.43 419.48 437.03 207.72 213.15 212.47 219.73 231.37 230.05 220.13 221.19 234.24 226.05
Total liabilities 7,711.62 7,769.98 7,338.61 7,138.36 7,312.37 7,687.65 7,651.40 8,428.45 7,834.79 7,480.34 7,800.86 7,871.07 7,603.08 7,328.21 7,875.36 7,748.04 7,494.50 7,366.70 7,235.91 7,418.59 7,735.12 7,646.71 7,748.25 7,923.09 8,093.61 8,155.28 8,010.46 8,675.97 8,708.73 3,724.65 2,102.68 2,093.00 2,089.05 2,276.48 2,270.26 2,309.14 2,406.82 2,097.62 1,922.77 1,947.73 1,812.88 2,027.51 2,031.52 2,089.23 2,090.02 2,080.51 2,040.88 1,983.33 2,028.51 1,972.54 1,906.05 1,657.20 1,732.24 1,661.31 1,510.97 1,517.75 1,505.16 1,446.50 1,454.23 597.16 649.75 587.54 595.18 599.37 658.53 646.57 651.11 706.35 635.82
Total stockholders' equity + 7,807.31 7,648.16 7,130.70 6,865.26 6,935.08 7,418.27 6,920.75 7,798.42 7,273.26 6,741.93 7,070.35 6,921.05 6,354.12 6,175.98 6,712.93 6,316.83 5,683.02 5,331.33 5,323.94 5,238.26 5,173.04 4,635.35 4,662.40 4,686.76 4,723.48 4,872.07 4,865.71 4,870.37 5,159.58 2,038.68 2,168.36 2,043.50 1,997.42 2,113.89 2,085.73 2,014.57 1,894.26 1,981.58 1,819.16 1,808.68 1,948.69 2,098.86 2,119.44 2,165.24 2,137.05 2,503.48 2,463.88 2,388.58 2,470.74 2,382.90 2,282.37 2,212.07 2,159.94 2,062.16 1,912.73 1,891.61 2,012.35 1,917.17 1,987.71 2,071.31 2,091.92 2,048.16 2,068.81 2,040.80 2,121.34 2,063.66 2,045.72 2,011.45 1,876.91
Common shares outstanding 3,125 3,205 3,155 3,176 3,163 3,170 3,220 3,178 3,137 3,170 3,131 3,130 3,228 3,141 3,127 3,109 3,152 3,150 3,161 3,109 3,147 3,151 3,146 3,132 3,115 3,115 3,124 3,122 3,137 1,577 1,575 1,573 1,563 1,573 1,572 1,570 1,562 1,569 1,568 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137 3,137
about 2 months ago
Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08 Mar-07
Operating cash flow + 995.32 1,057.18 716.34 977.16 1,123.11 1,010.93 669.75 328.48 377.85 261.36 25.49 182.52 148.34 307.71 336.57 326.94 381.17 326.27 292.50 209.28
Cash flow from investing + -411.19 -367.06 -463.86 -607.10 -198.13 393.53 292.12 -2,835.70 -93.34 -655.69 -71.21 91.35 -158.61 -111.38 -1,093.96 -99.26 -117.52 -767.26 101.75 116.39
Cash flow from financing + -398.08 -751.43 -354.42 -709.15 -1,070.27 -1,088.35 -1,005.21 2,946.24 -326.23 289.90 -124.84 -301.00 101.44 -150.56 393.79 -146.54 -148.05 -425.84 -262.08 -315.94
Change in cash 186.05 -61.30 -101.93 -339.09 -145.29 316.11 -43.34 439.02 -41.71 -104.43 -170.56 -27.13 91.17 45.77 -363.61 81.14 115.60 -866.82 132.16 9.73
Change in exchange rate 0.00 0.00 0.00 0.00
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08
Operating cash flow + 19.66 360.04 378.23 215.42 222.16 383.76 280.96 170.30 278.59 146.45 198.91 92.40 293.69 378.23 220.99 84.24 375.58 347.51 233.15 166.86 400.96 217.96 246.15 145.86 185.44 143.23 220.30 120.79 117.48 93.16 77.36 40.47 125.75 85.08 92.47 74.56 124.46 25.13 61.00 50.77 -145.08 75.60 76.33 18.64 32.98 64.88 72.62 12.04 105.45 49.99 82.26 -89.37 118.68 59.20 110.16 38.90 112.39 79.34 112.93 76.51 144.46 52.66
Cash flow from investing + -58.42 -247.98 -48.13 -33.19 -19.68 -115.56 -75.13 -156.69 -61.48 -75.27 -327.11 -266.53 -607.10 -168.61 -27.21 -94.71 -25.64 -69.14 -32.90 -70.45 293.33 71.98 27.56 0.66 36.25 -74.54 372.02 -41.60 -1,221.66 -1,611.89 14.95 -17.09 -107.52 -9.01 -76.14 99.33 -615.65 -28.97 -5.45 -5.61 28.06 -58.35 -20.56 -20.36 -12.09 77.96 -4.03 29.50 -15.29 -131.99 4.80 -16.13 -5.79 -30.88 -41.39 -21.20 -57.66 -20.81 -16.61 -22.45 6.27 9.17
Cash flow from financing + -31.72 -169.51 -11.98 -214.90 -301.79 -655.97 -110.05 316.38 -58.22 -97.76 -140.66 -57.78 -6.60 -434.96 -51.88 -215.72 -243.80 -168.06 -247.37 -411.04 -370.07 -300.07 -225.45 -192.77 -143.93 -49.61 -633.97 -177.70 1,534.26 1,509.15 -15.01 -82.16 -149.96 -68.13 -20.30 -87.83 258.45 -66.64 -14.35 112.44 38.03 -64.57 -11.72 -86.57 -131.83 -63.05 -26.86 -79.26 -7.90 -66.75 240.03 -63.93 -9.65 -63.83 -9.34 -63.73 -11.12 -62.87 -8.81 -65.25 -7.89 -187.01
Change in cash -70.49 -57.45 318.11 -32.67 -99.31 -387.77 95.79 329.99 158.88 -26.58 -268.86 -231.91 -320.01 -225.34 141.91 -226.19 106.15 110.31 -47.12 -314.63 324.22 -10.14 48.27 -46.24 77.75 19.08 -41.66 -98.51 430.08 -9.58 77.30 -58.78 -131.74 7.93 -3.98 86.07 -232.74 -70.48 41.20 157.59 -78.99 -47.33 44.04 -88.28 -110.94 79.79 41.73 -37.72 82.26 -148.75 327.08 -169.43 0.00 0.00 0.00 103.24 -35.51 59.43 -46.03 43.61 -4.34 87.52 -11.19 142.84 -125.18
Change in exchange rate 0.00 0.00 0.00 0.00 0.00 0.00 0.00
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Cash And Cash Equivalents At Carrying Value

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Total Current Assets

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Total Assets

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Capital Lease Obligations

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Accumulated Depreciation Amortization Ppe

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Treasury Stock

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Other Non Current Liabilities

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Current Long Term Debt

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Long Term Debt

1Y 2Y 5Y Max
about 2 months ago

TAKEDA PHARMACEUTICAL CO LTD (TAK) - Short Term Investments

1Y 2Y 5Y Max
about 2 months ago